EASE Appoints Dr. Kanyinsola Oyeyinka as CEO, Driving Medical Equipment-as-a-Service in Africa
EASE Holdings BV has promoted Dr. Kanyinsola Oyeyinka to Chief Executive Officer to succeed Imraan Soomra, who will, effective May 1, take on a new role as Non-Executive Director of EASE South Africa, the group’s most advanced unit.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250423749021/en/

Dr. Kanyinsola Oyeyinka speaks at a healthcare event in Rustenburg, South Africa, in January 2025, where she shared insights from EASE’s growing footprint across the continent.
The appointments come as EASE accelerates the rollout of its Equipment-as-a-Service model, which enables clinics and hospitals to access state-of-the-art PET-CT and MRI scanners, surgical robots, and other high-value machines without significant capital outlay by paying on a per-scan or per-event basis to align their costs with revenue. EASE South Africa is set to lead the rapid expansion of the service after announcing an agreement this month for Standard Bank to provide debt funding for future installations.
Dr. Oyeyinka, who previously served in the UK National Health Service as a medical doctor and had senior roles at the World Bank and the Nigeria Sovereign Investment Authority, has worked across the full healthcare value chain from frontline clinical care to building sustainable diagnostic and oncology platforms and shaping systems-level health reforms. During her three years as Senior Vice President at EASE, Dr. Oyeyinka has led operations in South Africa and Ghana, and driven strategic cross-border scaling with a clear vision for delivering world-class medical technology across Africa and other emerging markets.
“It is thanks to the coordinated leadership between Imraan and Kanyinsola that EASE has built a solid foundation, secured commercial debt funding, and grown our installed base through trusted partnerships,” said Frans van Schaik, Chairman of EASE. “Through her vast experience and commitment, Kanyinsola brings continuity, clarity and passion in taking over the mantle from Imraan, who remains central to driving the biggest component of the EASE network in South Africa.”
EASE’s equipment-as-a-service model has been proven with several installations in recent months. Commissioning of a PET-CT scanner at the Precision Nuclear Oncology and Theranostics facility (PNOAT) in Rustenburg, South Africa, earlier this year followed the deployment of a da Vinci surgical robot in KwaZulu-Natal, South Africa, and an advanced MRI diagnostic imaging system in Akwatia, Ghana.
Without the burden of heavy upfront equipment costs, a longstanding barrier for many healthcare centres in accessing the latest technology, capital is freed up for priorities such as increasing hospital beds and nursing staff. A first-of-its-kind for Africa, this initiative is set to change the healthcare landscape for many hospitals and clinics.
“EASE is more than a business; it’s a platform to rethink how healthcare infrastructure is delivered, financed, and sustained,” Dr. Oyeyinka said. “I’m proud to lead an organisation that is empowering hospitals and clinics to be more deliberate in their use of limited resources to better serve patients.”
The culmination of long-term strategic planning, EASE’s leadership transition ensures that the company enters its next chapter with both stability and momentum. The role draws on the full spectrum of Dr. Oyeyinka’s experience, having served as a doctor, a health financing consultant, a healthcare investment adviser and a member of EASE’s management team.
“Dr. Oyeyinka truly embodies our mission and has been central to our journey to this point,” said Imraan Soomra. “I look forward to continuing our work together with Dr. Oyeyinka at the helm developing EASE in its next international growth phase.”
About EASE
Equipment-as-a-Service (EASE®) is a pay-per-use program that provides businesses and organisations with cost-effective access to state-of-the-art healthcare equipment – and maintenance, training and support – with terms that match their circumstances and business needs. EASE South Africa is a subsidiary of EASE Holdings BV which is headquartered in the Netherlands and has operations in multiple African countries. To find out more about EASE, visit https://www.easeglobal.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250423749021/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Everen Specialty Appoints Carla Greaves Chief Underwriting Officer25.4.2025 19:00:00 CEST | Press release
Everen Specialty, a Bermuda-based (re)insurer for energy markets worldwide, today announced the appointment of Carla Greaves as its new Chief Underwriting Officer (CUO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425273777/en/ Carla Greaves Ms. Greaves will join the Executive Leadership Team of the Everen Group, based in the Bermuda office, later this year. She succeeds Jane Peterson, Interim CUO, who will continue in a consultancy capacity to facilitate the transition. With more than 30 years of underwriting and leadership experience in the (re)insurance industry, Ms. Greaves brings a wealth of expertise and a proven track record of success in the Casualty market where she is recognized for building high-performing teams, driving profitable growth, and successfully navigating complex market environments. Prior to joining Everen Specialty, Ms. Greaves held increasingly senior leadership positions, most recently servin
Incyte to Highlight Early-Stage Oncology Data at American Association for Cancer Research Annual Meeting 202525.4.2025 14:00:00 CEST | Press release
Incyte (Nasdaq:INCY) today announced that the Company will present new early-stage data from its oncology portfolio at the American Association of Cancer Research (AACR) Annual Meeting 2025 in Chicago, IL, from April 25–30. “At AACR we will be presenting data from early-stage programs across our oncology portfolio, including for patients with myeloproliferative neoplasms, ovarian cancer and other solid tumors,” said Pablo J. Cagnoni, M.D., President and Head of Research and Development, Incyte. “These data will guide our approach as we advance our pipeline and seek to transform the treatment landscape for patients with cancer and myeloproliferative neoplasms.” Abstracts accepted for presentation at AACR include: Mini Symposium INCB177054 INCB177054: A Novel, Potent, Orally Bioavailable DGKα/ζ Dual Inhibitor Enhances T-Cell Function and Demonstrates Potent Antitumor Activity (Session Title: Novel Antitumor Agents. April 28, 4:50 p.m. – 5:05 p.m. ET (3:50 p.m. – 4:05 p.m. CT). Abstract #
SLB Announces First-Quarter 2025 Results; Remains Committed to Return a Minimum of $4 Billion to Shareholders in 202525.4.2025 12:50:00 CEST | Press release
Revenue of $8.49 billion decreased 3% year on year GAAP EPS of $0.58 decreased 22% year on year EPS, excluding charges and credits, of $0.72 decreased 4% year on year Net income attributable to SLB of $797 million decreased 25% year on year Adjusted EBITDA of $2.02 billion decreased 2% year on year Cash flow from operations of $660 million increased $333 million year on year Board approved quarterly cash dividend of $0.285 per share SLB (NYSE: SLB) today announced results for the first-quarter 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250423635499/en/ The exterior of the SLB headquarters in Houston, Texas. First-Quarter Results (Stated in millions, except per share amounts) Three Months EndedChange Mar. 31, 2025 Dec. 31, 2024 Mar. 31, 2024 Sequential Year-on-year Revenue $8,490 $9,284 $8,707 -9% -3% Income before taxes - GAAP basis $1,063 $1,387 $1,357 -23% -22% Income before taxes margin - GAAP basis 12.5% 14.9%
Corona, The World’s Most Valuable Beer Brand1, Announces Its 100-Year Anniversary with Global Celebration25.4.2025 10:00:00 CEST | Press release
Brand Invites The World to Join the Celebration with Experiences at the Most Epic Beaches on EarthGlobal “Corona 100” Platform Launches with a Legendary Concert at Copacabana Beach, Featuring One of the World’s Top Musical Artists with Millions in Attendance Today, Corona proudly celebrates its 100-year anniversary, a remarkable milestone for the iconic brand that has been synonymous with the beach and enjoyed by consumers worldwide for the past century. Since 1925, Corona has cultivated a deep association with the beach; fully embodying a lifestyle connected to nature and relaxation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425804516/en/ Corona 100 This Is Living Since 1925 In honor of the occasion, Corona invites everyone to live their “beach side” – a.k.a. their best side – at top-tier beach locations across the globe. The Corona 100 platform includes a film highlighting 100 years of beach culture, a definitive l
Ant Group Unveils New Recruitment Initiative for Top AI Talents, Ramping Up AI Innovation Efforts25.4.2025 09:28:00 CEST | Press release
Ant Group today unveiled Plan A, a new recruitment initiative to attract top artificial intelligence researchers, reinforcing its commitment to accelerating AI research and development under the “AI First” corporate strategy. Operating within the framework of Ant Star—Ant Group’s year-round campus recruitment program—Plan A specifically targets AI talents who are ambitious, adaptable, altruistic, and analytical. Outstanding graduates from universities worldwide with STEM majors are encouraged to apply for Plan A. Relevant fields include computer science, software engineering, artificial intelligence, cybersecurity, information and telecommunication engineering, mathematics, statistics, and other emerging interdisciplinary areas. To better foster the development of technological innovators in this new AI era, Plan A offers candidates comprehensive support and resources, including unrestricted access to AI hardware and tailored career paths that allow for significant research freedom. Ad
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom